MX2023013066A - Formulaciones de etelcalcetida. - Google Patents
Formulaciones de etelcalcetida.Info
- Publication number
- MX2023013066A MX2023013066A MX2023013066A MX2023013066A MX2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A
- Authority
- MX
- Mexico
- Prior art keywords
- etelcalcetide
- formulations
- surfactant
- formulation
- salt
- Prior art date
Links
- ANIAZGVDEUQPRI-ZJQCGQFWSA-N etelcalcetide Chemical compound NC(N)=NCCC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O ANIAZGVDEUQPRI-ZJQCGQFWSA-N 0.000 title abstract 2
- 229950006502 etelcalcetide Drugs 0.000 title abstract 2
- 108091022127 etelcalcetide hydrochloride Proteins 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
En la presente se divulgan formulaciones farmacéuticas que comprenden etelcalcetida o una sal de esta y un agente tensioactivo en solución acuosa, en donde la formulación tiene un pH de 2.0 a 5.0.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184924P | 2021-05-06 | 2021-05-06 | |
| PCT/US2022/027451 WO2022235654A1 (en) | 2021-05-06 | 2022-05-03 | Etelcalcetide formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023013066A true MX2023013066A (es) | 2023-11-15 |
Family
ID=81750502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023013066A MX2023013066A (es) | 2021-05-06 | 2022-05-03 | Formulaciones de etelcalcetida. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240207354A1 (es) |
| EP (1) | EP4333805A1 (es) |
| JP (1) | JP2024517801A (es) |
| AU (1) | AU2022268916A1 (es) |
| CA (1) | CA3218559A1 (es) |
| MX (1) | MX2023013066A (es) |
| WO (1) | WO2022235654A1 (es) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| WO2011002853A2 (en) * | 2009-07-01 | 2011-01-06 | Fresenius Medical Care Holdings, Inc. | Drug delivery devices and related systems and methods |
| PE20210413A1 (es) | 2013-06-28 | 2021-03-04 | Amgen Inc | Formulacion liquida estable que comprende etelcalcetida (amg416), un agente tamponante y agente de tonicidad |
| WO2021080822A1 (en) * | 2019-10-24 | 2021-04-29 | Amgen Inc. | Systems and methods for drug delivery |
-
2022
- 2022-05-03 US US18/288,410 patent/US20240207354A1/en active Pending
- 2022-05-03 WO PCT/US2022/027451 patent/WO2022235654A1/en active Application Filing
- 2022-05-03 MX MX2023013066A patent/MX2023013066A/es unknown
- 2022-05-03 AU AU2022268916A patent/AU2022268916A1/en active Pending
- 2022-05-03 EP EP22725053.7A patent/EP4333805A1/en active Pending
- 2022-05-03 JP JP2023567187A patent/JP2024517801A/ja active Pending
- 2022-05-03 CA CA3218559A patent/CA3218559A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3218559A1 (en) | 2022-11-10 |
| JP2024517801A (ja) | 2024-04-23 |
| EP4333805A1 (en) | 2024-03-13 |
| WO2022235654A1 (en) | 2022-11-10 |
| AU2022268916A1 (en) | 2023-11-09 |
| US20240207354A1 (en) | 2024-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200302105T4 (tr) | Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları. | |
| IN2015MU00865A (es) | ||
| UY26269A1 (es) | Formulación de sal común y moxifloxacina | |
| MX2017007178A (es) | Formulaciones liquidas estables de virus de vacuna. | |
| HUP0401811A2 (hu) | Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására | |
| NZ738597A (en) | Stuffy nose deblocking composition having antiviral activity | |
| MX2018014631A (es) | Formulacion de neurotoxina. | |
| AR074541A1 (es) | Composiciones desinfectantes de plata naturales | |
| CR8473A (es) | Composicion farmaceutica de vinflunina para administracion parenteral y proceso de preparacion de dicha composicion | |
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| MXPA03011480A (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral. | |
| ZA202300259B (en) | Compound for the treatment of coronaviral infections | |
| WO2019094684A3 (en) | Aqueous compositions comprising dicamba and a built-in drift control agent | |
| BR112022008655A2 (pt) | Composições de copolímero em bloco responsivas ao ph, micelas, e métodos de uso | |
| AR111550A1 (es) | Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico | |
| MX2023013066A (es) | Formulaciones de etelcalcetida. | |
| PH12021550236A1 (en) | Thickener combination for agrochemical (crop protection) formulations with high salt content | |
| TN2014000152A1 (en) | Sustained-release preparation | |
| MX2007009076A (es) | Composiciones polimericas y su uso para la preparacion de composiciones de principios activos o compuestos eficaces. | |
| PL431139A1 (pl) | Kompozycja farmaceutyczna bimatoprostu i tymololu | |
| DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| TR201909422T4 (tr) | Flurbiprofen ve dekspantenolün oral topikal sulu farmasötik bileşimleri. | |
| AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| MX2022001630A (es) | Composicion fungicida. | |
| MX2019007608A (es) | Composicion liquida de fibrinogeno humano. |